Tuesday, September 20, 2016 9:38:01 AM
N1 Technologies announcing the filing of a new BioPhage based
Testing Kit Patent. The new product is a mini lab for the onsite
testing for the presence of Staph and Strep bacteria. The company
hopes to market the test kits in conjunction with there BioPhage
based Staph and Strep biopharmaceuticals.
www.N1Technologies.com
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM